Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 72 Neoplasms 7 Neoplasm Metastasis 7 Breast Diseases 5 Neoplasms by Site 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasm Female 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 HER2 Negative Breast Cancer 1 Granulosa Cell Ovarian Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Stromal Tumors 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1

Interventions

Letrozole 2 Bupivacaine 2 pyrotinib 1 exemestane 1 abemaciclib 1 Tumor Burden 1 Thioctic Acid 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1 Mastectomy, Segmental 1 Mastectomy 1 Mammaplasty 1 Drug Therapy 1 Dexmedetomidine 1 Control Groups 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Anastrozole × 1 year × Clear all

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡